de Jong MD - Search Results

1

Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.

de Jong MD, Boucher CA, Cooper DA, Galasso GJ, Gazzard B, Lange JM, Montaner JS, Richman DD, Thomas HC. de Jong MD, et al. Antiviral Res. 1997 Jul;35(2):65-82. doi: 10.1016/s0166-3542(97)00020-x. Antiviral Res. 1997. PMID: 9217244 Free PMC article. No abstract available.

2

Consensus symposium on combined antiviral therapy. International Society for Antiviral Research and the National Institutes of Allergy and Infectious Diseases.

de Jong MD, Boucher CA, Galasso GJ, Hirsch MS, Kern ER, Lange JM, Richman DD. de Jong MD, et al. Antiviral Res. 1996 Jan;29(1):5-29. doi: 10.1016/0166-3542(95)00910-8. Antiviral Res. 1996. PMID: 8721539 Review. No abstract available.

3

Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.

de Jong MD, Boucher CA, Danner SA, Gazzard B, Griffiths PD, Katlama C, Lange JM, Richman DD, Vella S. de Jong MD, et al. Antiviral Res. 1998 Jan;37(1):1-16. doi: 10.1016/s0166-3542(97)00059-4. Antiviral Res. 1998. PMID: 9497068 Review. No abstract available.

4

Summary of the II International Symposium on Cytomegalovirus.

de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA. de Jong MD, et al. Antiviral Res. 1998 Oct;39(3):141-62. doi: 10.1016/s0166-3542(98)00044-8. Antiviral Res. 1998. PMID: 9833956 Free article.

5

Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure.

de Jong MD, Schuurman R, Lange JM, Boucher CA. de Jong MD, et al. Antivir Ther. 1996 Jan;1(1):33-41. Antivir Ther. 1996. PMID: 11322257

6

The clinical significance of the biological phenotype of HIV.

Lange JM, de Jong MD. Lange JM, et al. Among authors: de jong md. AIDS Clin Rev. 1993-1994:1-18. AIDS Clin Rev. 1993. PMID: 8217894 Review. No abstract available.

7

A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individuals.

Weverling GJ, Lange JM, de Jong MD, de Weerd H, Goudsmit J, de Wolf F. Weverling GJ, et al. Among authors: de jong md, de weerd h, de wolf f. Antivir Ther. 1996 Dec;1(4):255-63. Antivir Ther. 1996. PMID: 11324828 Clinical Trial.

8

Highlights of the Fourth International Workshop on HIV Drug Resistance.

Lange JM, deJong MD. Lange JM, et al. J Int Assoc Physicians AIDS Care. 1995 Aug;1(7):25-7. J Int Assoc Physicians AIDS Care. 1995. PMID: 11362748

9

Clinical, virological and immunological features of primary HIV-1 infection.

de Jong MD, Hulsebosch HJ, Lange JM. de Jong MD, et al. Genitourin Med. 1991 Oct;67(5):367-73. doi: 10.1136/sti.67.5.367. Genitourin Med. 1991. PMID: 1743707 Free PMC article. Review. No abstract available.

10

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.

de Jong MD, de Boer RJ, de Wolf F, Foudraine NA, Boucher CA, Goudsmit J, Lange JM. de Jong MD, et al. Among authors: de boer rj, de wolf f. AIDS. 1997 Sep;11(11):F79-84. doi: 10.1097/00002030-199711000-00002. AIDS. 1997. PMID: 9302437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

360 results

Search Page

Filters